News | News By Subject | News by Disease News By Date | Search News

Fungal infection (non-specific) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
FDA Warns Against Off-Label Use of Johnson & Johnson (JNJ)'s Nizoral Tablets to Treat Skin And Nail Infections, Linked to Patient Death     5/20/2016
What You Need to Know About Novan Therapeutics     11/16/2015
San Diego’s Amplyx Bags $41 Million to Fight a Deadly Fungus     11/11/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
FDA Rejects Valeant Pharmaceuticals International (VRX)'s Nail Infection Drug     5/29/2013
Anacor Pharmaceuticals, Inc. (ANAC) Reveals Positive Data From Second Phase-3 Trial of Tavaborole     3/1/2013
Anacor Pharmaceuticals, Inc. (ANAC) Falls on Positive But Disappointing Toenail Fungus Data     1/30/2013
Pfizer Inc. (PFE) Fungal Infection Therapy Fails Trial Goal     10/3/2011
Novartis AG Sees $590 Million Charge Because of Drug Trial Stoppages for Antifungal Agent Mycograb as Well as Zalbin     10/5/2010
Basilea Pharmaceutica Partners with Astellas Pharma Inc. (JOBS) for Late Stage Anti-Fungal; to Get 75 Million Swiss Francs Upfront; Deal Potentially Worth 478 Million Francs     2/24/2010
FDA Staff Suggests Liver Warning on Merck & Co., Inc. (MRK)'s (JOBS) Cancidas     12/4/2009
NexMed (NEXM), Novartis Corporation (NVS) End Phase 3 Anti-Fungal Drug Development     7/8/2009
Anacor Pharmaceuticals, Inc. Fungal Drug Passes Early Test     3/4/2009

News from Around the Web
A Faster And More Effective Detector Of Fungal Infections, Institute Of Physical Chemistry Of The Polish Academy of Sciences Study     4/28/2016
Genes May Open Door to Chronic Fungal Infection, Radboud University Nijmegen Medical Centre Study     7/1/2011
Antifungal Compound Found on Tropical Seaweed has Promising Antimalarial Properties, Georgia Institute of Technology Study Finds     2/22/2011
Vitamin B3 as a Novel Approach to Treat Fungal Infections, University Of Montreal Study     8/11/2010
Scientists Demonstrate Antifungal Properties Of Vitamin B3, University Of Montreal and Biotechnology Research Institute - NRC Study     7/12/2010
Genetic Links To Fungal Infection Risk Identified, University College London and Radboud University Study     11/2/2009
Key To Virulence Protein Entry Into Host Cells Discovered by Virginia Bioinformatics Institute Researchers     8/5/2008
Southern Illinois University Carbondale: New Lab Test Can Detect Costly Fungal Disease In Soybean Seedlings     1/10/2008
Gamma Interferon Could Aid Fight Against Fungal Infections     11/1/2007
Schering-Plough Corporation (SGP) Drug Prevents Fungus In Patients     1/25/2007
Fungal Disease Killing L.A. Palm Trees     10/18/2006
The Day In Review: Schering-Plough Corporation (SGP) Gets Approval For Noxafil     9/18/2006
Genome Of Sudden Oak Death Bug Cracked     6/14/2004

Press Releases
Pfizer (PFE) Completes License Agreement For The Exclusive Commercialization Rights In Europe For CRESEMBA (Isavuconazole), A Novel Treatment For Potentially Life-Threatening Fungal Infections Among Immunocompromised Patients     7/20/2017
SCYNEXIS, Inc. (SCYX) Release: Eight Presentations At ASM Microbe 2017 Further Highlight The Strong Antifungal Effect And Promising Safety Profile Of Lead Anti-Infective Candidate SCY-078     6/5/2017
Potent In Vitro Activity Of SCYNEXIS, Inc. (SCYX)’ SCY-078 Against Multidrug-Resistant Fungal Pathogen Candida Auris Further Confirmed In An In Vitro Study Conducted By The CDC     5/11/2017
Fugacil Release: Newly Launched Nail Fungus Treatment Fugacil Makes Its Way To South Korea     4/18/2017
Case Western Reserve University Release: First Systematic Study Of Deadly, Antibiotic-Resistant Fungus Reported     2/27/2017
Pulmatrix (PULM) Jumps on News From the FDA     1/18/2017
SCYNEXIS, Inc. (SCYX) Achieves New Development Milestones Reinforcing The Versatility Of SCY-078 In Treating Serious Fungal Infections     12/13/2016
FDA Grants Orphan Drug Designation To Amplyx For APX001 For Treatment Of Multiple Invasive Fungal And Mold Infections     11/16/2016
Hallux Release: Clinical Research Study In Toenail Fungus Open For Enrollment In Mesa, Arizona     11/8/2016
SCYNEXIS, Inc. (SCYX) Completes Two Additional Clinical Studies Further Supporting The Favorable Safety Profile Of SCY-078     10/25/2016
Matinas BioPharma's Lead Antifungal Product Candidate MAT2203 Granted QIDP And Fast Track Designations For Prophylaxis Of Invasive Fungal Infections By U.S. FDA     9/7/2016
Mo Bio Laboratories, Inc. Launches The AllPrep Bacterial And Fungal DNA/RNA/Protein Kits     9/7/2016
Novan Announces First Patient Dosed In Phase 2 Anti-Fungal Program     7/21/2016
Vyome To Present Data On Breakthrough Molecular Replacement Therapy (MRT) Targeting Fungal Infections At ASM Microbe 2016 Conference, Boston     6/15/2016
Clinigen Announces Partnership With Basilea (BSLN.SW) To Initiate A Managed Access Program For Isavuconazole To Treat Patients With Invasive Fungal Infections In Europe     6/9/2016